This week, the world heard encouraging news about a vaccine for COVID-19.

On Monday, the pharmaceutical company Pfizer, and its partner BioNTech, said their experimental vaccine appears to work – and work quite well. A preliminary analysis suggests the vaccine is more than 90 percent effective at preventing COVID-19 symptoms.

Health officials hope to start vaccinating some Americans in a few months.

"The vaccine is on its way, folks," Dr. Anthony Fauci told a crowd Tuesday, via video link, outside Brooklyn Borough Hall.

But what about the rest of world, especially people in poorer counties. Is the vaccine "on its way for them?"

Virus surge: Schools abandon classes, states retreat School systems in Detroit, Indianapolis, Philadelphia and suburban Minneapolis are giving up on in-person classes, and some governors are reimposing restrictions on bars and restaurants or getting... AP NEWS

School systems in Detroit, Indianapolis, Philadelphia and suburban Minneapolis are giving up on in-person classes, and some governors are reimposing restrictions on bars and restaurants or getting more serious about masks, as the coast-to-coast resurgence of the coronavirus sends deaths, hospitalizations and new infections soaring.

U.S. prepares for worst four months of the pandemic as it stares down the 'darkest' days yet The U.S. is heading for a “dark winter,” a “Covid hell" that will make the next few months of the coronavirus pandemic unlike anything the nation has seen yet. Will Feuer CNBC

• Epidemiologists, scientists and public health officials are warning that the United States has yet to see the most difficult days of the coronavirus outbreak.

Can a nose-full of chicken antibodies ward off coronavirus infections? A novel project aims to temporarily protect humans from COVID-19 with a nasal spray Science | AAAS

While the world waits for a widely available, safe, and effective COVID-19 vaccine, scientists are becoming ever more creative in their search for other ways to protect people from the disease. Now, a clinical trial has begun in Australia to find out whether nasal drops that contain chicken antibodies to SARS-CoV-2 can offer temporary protection.

One in five COVID-19 patients develop mental illness within 90 days of diagnosis, new study finds Those with previous psychiatric diagnoses were 65% more likely to contract the coronavirus PhillyVoice

Psychiatrists are placing more attention on COVID-19's damaging impact on mental health following startling results from a new study.